Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming-Huang Chen

Showing results (21-30 of 183) with videos related to

Pageof 19
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 25, 2020
Low but Long-lasting Risk of Reversal of Seroconversion in Patients With Rheumatoid Arthritis Receiving Immunosuppressive TherapyMing-Han Chen, Ming-Huang Chen, Chung-Tei Chou, et al.
International Journal of Molecular Sciences|September 10, 2021
High Risk of Viral Reactivation in Hepatitis B Patients with Systemic Lupus ErythematosusMing-Han Chen, Chien-Sheng Wu, Ming-Huang Chen, et al.
Modern Rheumatology|April 4, 2015
Upregulation of BMP-2 expression in peripheral blood mononuclear cells by proinflammatory cytokines and radiographic progression in ankylosing spondylitisMing-Han Chen, Hung-An Chen, Wei-Sheng Chen, et al.
Oncotarget|May 6, 2017
Efficacy of an HSP90 inhibitor, ganetespib, in preclinical thyroid cancer modelsShu-Fu Lin, Jen-Der Lin, Chuen Hsueh, et al.
Journal for Immunotherapy of Cancer|September 1, 2020
Risk of HBV reactivation in patients with immune checkpoint inhibitor-treated unresectable hepatocellular carcinomaPei-Chang Lee, Yee Chao, Ming-Huang Chen, et al.
BMC Cancer|January 12, 2022
Anti-PD-1 combined sorafenib versus anti-PD-1 alone in the treatment of advanced hepatocellular cell carcinoma: a propensity score-matching studySan-Chi Chen, Yi-Hsiang Huang, Ming-Huang Chen, et al.
Vaccines|December 1, 2020
Comprehensive Evaluation of Immune-Checkpoint DNA Cancer Vaccines in a Rat Cholangiocarcinoma ModelYi-Ru Pan, Chiao-En Wu, Ming-Huang Chen, et al.
The American Journal of Surgical Pathology|September 26, 2017
C-Reactive Protein (CRP) is a Promising Diagnostic Immunohistochemical Marker for Intrahepatic Cholangiocarcinoma and is Associated With Better PrognosisYi-Chen Yeh, Hao-Jan Lei, Ming-Huang Chen, et al.
Frontiers in Oncology|February 7, 2022
Aldolase A and Phospholipase D1 Synergistically Resist Alkylating Agents and Radiation in Lung CancerYu-Chan Chang, Peter Mu-Hsin Chang, Chien-Hsiu Li, et al.
Journal of the Chinese Medical Association : JCMA|December 18, 2013
Lung involvement in primary Sjögren's syndrome: Correlation between high-resolution computed tomography score and mortalityMing-Han Chen, Hsiao-Ping Chou, Chien-Chih Lai, et al.
Pageof 19

Showing results (21-30 of 183) with videos related to

Sort By:
Pageof 19
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 25, 2020
Low but Long-lasting Risk of Reversal of Seroconversion in Patients With Rheumatoid Arthritis Receiving Immunosuppressive TherapyMing-Han Chen, Ming-Huang Chen, Chung-Tei Chou, et al.
International Journal of Molecular Sciences|September 10, 2021
High Risk of Viral Reactivation in Hepatitis B Patients with Systemic Lupus ErythematosusMing-Han Chen, Chien-Sheng Wu, Ming-Huang Chen, et al.
Modern Rheumatology|April 4, 2015
Upregulation of BMP-2 expression in peripheral blood mononuclear cells by proinflammatory cytokines and radiographic progression in ankylosing spondylitisMing-Han Chen, Hung-An Chen, Wei-Sheng Chen, et al.
Oncotarget|May 6, 2017
Efficacy of an HSP90 inhibitor, ganetespib, in preclinical thyroid cancer modelsShu-Fu Lin, Jen-Der Lin, Chuen Hsueh, et al.
Journal for Immunotherapy of Cancer|September 1, 2020
Risk of HBV reactivation in patients with immune checkpoint inhibitor-treated unresectable hepatocellular carcinomaPei-Chang Lee, Yee Chao, Ming-Huang Chen, et al.
BMC Cancer|January 12, 2022
Anti-PD-1 combined sorafenib versus anti-PD-1 alone in the treatment of advanced hepatocellular cell carcinoma: a propensity score-matching studySan-Chi Chen, Yi-Hsiang Huang, Ming-Huang Chen, et al.
Vaccines|December 1, 2020
Comprehensive Evaluation of Immune-Checkpoint DNA Cancer Vaccines in a Rat Cholangiocarcinoma ModelYi-Ru Pan, Chiao-En Wu, Ming-Huang Chen, et al.
The American Journal of Surgical Pathology|September 26, 2017
C-Reactive Protein (CRP) is a Promising Diagnostic Immunohistochemical Marker for Intrahepatic Cholangiocarcinoma and is Associated With Better PrognosisYi-Chen Yeh, Hao-Jan Lei, Ming-Huang Chen, et al.
Frontiers in Oncology|February 7, 2022
Aldolase A and Phospholipase D1 Synergistically Resist Alkylating Agents and Radiation in Lung CancerYu-Chan Chang, Peter Mu-Hsin Chang, Chien-Hsiu Li, et al.
Journal of the Chinese Medical Association : JCMA|December 18, 2013
Lung involvement in primary Sjögren's syndrome: Correlation between high-resolution computed tomography score and mortalityMing-Han Chen, Hsiao-Ping Chou, Chien-Chih Lai, et al.
Pageof 19